Magnesiumsulfat B. Braun

Magnesium sulfate, the active ingredient in Magnesiumsulfat B. Braun, is an electrolyte/mineral supplement presented as a sterile solution for intramuscular and intravenous use. It is employed to replace magnesium in patients with low serum levels and in specific obstetric and cardiac emergencies. GNH USA supplies Magnesiumsulfat B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Magnesium sulfate acts as a magnesium replacement therapy for conditions associated with low magnesium or excessive calcium activity. - Hypomagnesemia: restores serum magnesium concentrations and reduces neuromuscular irritability. - Eclampsia: prevents seizures by stabilising neuronal membranes in pregnant women with severe hypertension. - Pre‑eclampsia: helps control blood pressure and reduces risk of progression to eclampsia. - Torsades de pointes: shortens QT interval and lowers the risk of ventricular arrhythmias. - Severe asthma exacerbations: promotes bronchodilation and improves response to other therapies.

Adverse reactions may occur with intravenous or intramuscular administration.

Common Side Effects: - Flushing or warmth at the injection site - Mild hypotension - Nausea or vomiting - Transient headache - Dizziness or light‑headedness

Serious or Rare Side Effects: - Severe hypotension or shock - Cardiac arrest or severe arrhythmias - Respiratory depression - Hypermagnesemia with neuromuscular paralysis - Anaphylactic or severe allergic reactions

Magnesium sulfate should be used with careful clinical monitoring. - Renal impairment: adjust dose or avoid if severe renal failure is present. - Cardiac disease: monitor ECG and blood pressure continuously. - Neuromuscular disorders: watch for enhanced muscle weakness. - Pregnancy: use only when benefit outweighs potential risk to the fetus. - Concomitant calcium channel blockers: increase risk of hypotension and bradycardia. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Magnesium sulfate can alter the activity of several co‑administered drugs.

Major Interactions (Avoid): - Calcium channel blockers: additive hypotensive effect. - Neuromuscular blocking agents: prolonged paralysis.

Moderate Interactions (Monitor Closely): - Loop diuretics: may increase magnesium loss, requiring monitoring of serum levels. - Aminoglycoside antibiotics: risk of enhanced neuromuscular blockade. - Bisphosphonates: reduced absorption if given concurrently.